The elimination effort is based on a mass drug administration (MDA) approach that uses one of three anti-filarial drug regimens; i) ivermectin (IVM) plus albendazole (ALB) in regions of Africa where Onchocerca volvulus is co-endemic, ii) ALB alone in areas where LF is co-endemic with Loa loa, and iii) diethylcarbamazine (DEC) plus ALB in LF endemic areas outside of Africa and in regions of Africa where L. loa and O. volvulus are not present [4]. The gene discussed is ALB; the disease is Lassa fever.